Literature DB >> 24900702

Metabolically Stable tert-Butyl Replacement.

David Barnes-Seeman1, Monish Jain2, Leslie Bell2, Suzie Ferreira2, Scott Cohen1, Xiao-Hui Chen2, Jakal Amin2, Brad Snodgrass2, Panos Hatsis2.   

Abstract

Susceptibility to metabolism is a common issue with the tert-butyl group on compounds of medicinal interest. We demonstrate an approach of removing all the fully sp(3) C-Hs from a tert-butyl group: replacing some C-Hs with C-Fs and increasing the s-character of the remaining C-Hs. This approach gave a trifluoromethylcyclopropyl group, which increased metabolic stability. Trifluoromethylcyclopropyl-containing analogues had consistently higher metabolic stability in vitro and in vivo compared to their tert-butyl-containing counterparts.

Entities:  

Keywords:  Metabolic stability; clearance; metabolism; t-butyl; tert-butyl; tertiary butyl

Year:  2013        PMID: 24900702      PMCID: PMC4027455          DOI: 10.1021/ml400045j

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  13 in total

1.  Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes.

Authors:  R S Obach
Journal:  Drug Metab Dispos       Date:  1999-11       Impact factor: 3.922

2.  The use of in vitro metabolic stability for rapid selection of compounds in early discovery based on their expected hepatic extraction ratios.

Authors:  Yan Yi Lau; Gopal Krishna; Nathan P Yumibe; Diane E Grotz; Elpida Sapidou; Laura Norton; Inhou Chu; Cliff Chen; A D Soares; Chin-Chung Lin
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

3.  Oxetanes as promising modules in drug discovery.

Authors:  Georg Wuitschik; Mark Rogers-Evans; Klaus Müller; Holger Fischer; Björn Wagner; Franz Schuler; Liudmila Polonchuk; Erick M Carreira
Journal:  Angew Chem Int Ed Engl       Date:  2006-11-27       Impact factor: 15.336

4.  Discovery of pyrroloaminopyrazoles as novel PAK inhibitors.

Authors:  Chuangxing Guo; Indrawan McAlpine; Junhu Zhang; Daniel D Knighton; Susan Kephart; M Catherine Johnson; Haitao Li; Djamal Bouzida; Anle Yang; Liming Dong; Joseph Marakovits; Jayashree Tikhe; Paul Richardson; Lisa C Guo; Robert Kania; Martin P Edwards; Eugenia Kraynov; James Christensen; Joseph Piraino; Joseph Lee; Eleanor Dagostino; Christine Del-Carmen; Ya-Li Deng; Tod Smeal; Brion W Murray
Journal:  J Med Chem       Date:  2012-05-14       Impact factor: 7.446

5.  Orally bioavailable imidazoazepanes as calcitonin gene-related peptide (CGRP) receptor antagonists: discovery of MK-2918.

Authors:  Daniel V Paone; Diem N Nguyen; Anthony W Shaw; Christopher S Burgey; Craig M Potteiger; James Z Deng; Scott D Mosser; Christopher A Salvatore; Sean Yu; Shane Roller; Stefanie A Kane; Harold G Selnick; Joseph P Vacca; Theresa M Williams
Journal:  Bioorg Med Chem Lett       Date:  2010-12-30       Impact factor: 2.823

Review 6.  Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer.

Authors:  Sarah L Hulin-Curtis; Dominique Petit; W Douglas Figg; Ann W Hsing; Juergen K V Reichardt
Journal:  Future Oncol       Date:  2010-12       Impact factor: 3.404

7.  Biarylpyrazolyl oxadiazole as potent, selective, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity.

Authors:  Suk Ho Lee; Hee Jeong Seo; Sung-Han Lee; Myung Eun Jung; Ji-Hyun Park; Hyun-Ju Park; Jakyung Yoo; Hoseop Yun; Jooran Na; Suk Youn Kang; Kwang-Seop Song; Min-ah Kim; Chong-Hwan Chang; Jeongmin Kim; Jinhwa Lee
Journal:  J Med Chem       Date:  2008-11-27       Impact factor: 7.446

8.  Imidazopyridines as VLA-4 integrin antagonists.

Authors:  David J Phillips; Richard J Davenport; Thierry A Demaude; Fiona P Galleway; Mark W Jones; Laurent Knerr; Benjamin G Perry; Andrew J Ratcliffe
Journal:  Bioorg Med Chem Lett       Date:  2008-05-23       Impact factor: 2.823

9.  Identification of finasteride metabolites in human bile and urine by high-performance liquid chromatography/tandem mass spectrometry.

Authors:  Anna Lundahl; Hans Lennernäs; Lars Knutson; Ulf Bondesson; Mikael Hedeland
Journal:  Drug Metab Dispos       Date:  2009-07-27       Impact factor: 3.922

Review 10.  Cytochrome p450 and chemical toxicology.

Authors:  F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2007-12-06       Impact factor: 3.739

View more
  15 in total

1.  Discovery of Orally Active Hydroxyethylamine Based SPPL2a Inhibitors.

Authors:  Juraj Velcicky; Casey J N Mathison; Victor Nikulin; Daniel Pflieger; Robert Epple; Mihai Azimioara; Christopher Cow; Pierre-Yves Michellys; Pascal Rigollier; Daniel R Beisner; Ursula Bodendorf; Danilo Guerini; Bo Liu; Ben Wen; Samantha Zaharevitz; Trixi Brandl
Journal:  ACS Med Chem Lett       Date:  2019-05-23       Impact factor: 4.345

2.  Novel Toxoplasma gondii inhibitor chemotypes.

Authors:  A G Sanford; T T Schulze; L P Potluri; R M Hemsley; J J Larson; A K Judge; S J Zach; X Wang; S A Charman; J L Vennerstrom; P H Davis
Journal:  Parasitol Int       Date:  2018-01-04       Impact factor: 2.230

3.  Repurposing the antihistamine terfenadine for antimicrobial activity against Staphylococcus aureus.

Authors:  Jessamyn I Perlmutter; Lauren T Forbes; Damian J Krysan; Katherine Ebsworth-Mojica; Jennifer M Colquhoun; Jenna L Wang; Paul M Dunman; Daniel P Flaherty
Journal:  J Med Chem       Date:  2014-10-06       Impact factor: 7.446

4.  Strategies for the expression and characterization of artificial myoglobin-based carbene transferases.

Authors:  Daniela M Carminati; Eric J Moore; Rudi Fasan
Journal:  Methods Enzymol       Date:  2020-08-06       Impact factor: 1.600

5.  Discovery and Optimization of Salicylic Acid-Derived Sulfonamide Inhibitors of the WD Repeat-Containing Protein 5-MYC Protein-Protein Interaction.

Authors:  Jonathan D Macdonald; Selena Chacón Simon; Changho Han; Feng Wang; J Grace Shaw; Jennifer E Howes; Jiqing Sai; Joannes P Yuh; Demarco Camper; Bethany M Alicie; Joseph Alvarado; Sameer Nikhar; William Payne; Erin R Aho; Joshua A Bauer; Bin Zhao; Jason Phan; Lance R Thomas; Olivia W Rossanese; William P Tansey; Alex G Waterson; Shaun R Stauffer; Stephen W Fesik
Journal:  J Med Chem       Date:  2019-12-05       Impact factor: 7.446

6.  Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii.

Authors:  Florentine U Rutaganira; Jennifer Barks; Mary Savari Dhason; Qiuling Wang; Michael S Lopez; Shaojun Long; Joshua B Radke; Nathaniel G Jones; Amarendar R Maddirala; James W Janetka; Majida El Bakkouri; Raymond Hui; Kevan M Shokat; L David Sibley
Journal:  J Med Chem       Date:  2017-10-09       Impact factor: 7.446

7.  Simple sulfinate synthesis enables C-H trifluoromethylcyclopropanation.

Authors:  Ryan Gianatassio; Shuhei Kawamura; Cecil L Eprile; Klement Foo; Jason Ge; Aaron C Burns; Michael R Collins; Phil S Baran
Journal:  Angew Chem Int Ed Engl       Date:  2014-08-03       Impact factor: 15.336

Review 8.  Put a ring on it: application of small aliphatic rings in medicinal chemistry.

Authors:  Matthias R Bauer; Paolo Di Fruscia; Simon C C Lucas; Iacovos N Michaelides; Jennifer E Nelson; R Ian Storer; Benjamin C Whitehurst
Journal:  RSC Med Chem       Date:  2021-01-07

9.  Discovery of a novel series of potent non-nucleoside inhibitors of hepatitis C virus NS5B.

Authors:  Ryan C Schoenfeld; David L Bourdet; Ken A Brameld; Elbert Chin; Javier de Vicente; Amy Fung; Seth F Harris; Eun K Lee; Sophie Le Pogam; Vincent Leveque; Jim Li; Alfred S-T Lui; Isabel Najera; Sonal Rajyaguru; Michael Sangi; Sandra Steiner; Francisco X Talamas; Joshua P Taygerly; Junping Zhao
Journal:  J Med Chem       Date:  2013-10-10       Impact factor: 7.446

10.  Discovery of N-[4-[6-tert-butyl-5-methoxy-8-(6-methoxy-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide (RG7109), a potent inhibitor of the hepatitis C virus NS5B polymerase.

Authors:  Francisco X Talamas; Sarah C Abbot; Shalini Anand; Ken A Brameld; David S Carter; Jun Chen; Dana Davis; Javier de Vicente; Amy D Fung; Leyi Gong; Seth F Harris; Petra Inbar; Sharada S Labadie; Eun K Lee; Remy Lemoine; Sophie Le Pogam; Vincent Leveque; Jim Li; Joel McIntosh; Isabel Nájera; Jaehyeon Park; Aruna Railkar; Sonal Rajyaguru; Michael Sangi; Ryan C Schoenfeld; Leanna R Staben; Yunchou Tan; Joshua P Taygerly; Armando G Villaseñor; Paul E Weller
Journal:  J Med Chem       Date:  2013-11-06       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.